{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:58:50Z","timestamp":1768355930159,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,30]]},"DOI":"10.7759\/cureus.17565","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T14:36:30Z","timestamp":1630334190000},"source":"Crossref","is-referenced-by-count":4,"title":["Review of the Literature on Ocular Complications Associated With Aromatase Inhibitor Use"],"prefix":"10.7759","author":[{"given":"Ibrahim","family":"Almafreji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraser","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.594202","article-title":"Breast cancer medications and vision: effects of treatments for early-stage disease","volume":"36","author":"Eisner A","year":"2011","unstructured":"Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res. 2011, 36:867-85. 10.3109\/02713683.2011.594202","journal-title":"Curr Eye Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2000.078002146.x","article-title":"Identification of androgen, estrogen and progesterone receptor mRNAs in the eye","volume":"78","author":"Wickham LA","year":"2000","unstructured":"Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand. 2000, 78:146-53. 10.1034\/j.1600-0420.2000.078002146.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.7.877","article-title":"Presence of oestrogen receptor type beta in human retina","volume":"85","author":"Munaut C","year":"2001","unstructured":"Munaut C, Lambert V, No\u00ebl A, Frankenne F, Deprez M, Foidart JM, Rakic JM. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol. 2001, 85:877-82. 10.1136\/bjo.85.7.877","journal-title":"Br J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01713.x","article-title":"Aromatase in the brain: not just for reproduction anymore","volume":"20","author":"Garcia-Segura LM","year":"2008","unstructured":"Garcia-Segura LM. Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol. 2008, 20:705-12. 10.1111\/j.1365-2826.2008.01713.x","journal-title":"J Neuroendocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/er.2004-0015","article-title":"Aromatase inhibitors in the treatment of breast cancer","volume":"26","author":"Brueggemeier RW","year":"2005","unstructured":"Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Aromatase inhibitors in the treatment of breast cancer. Endocr Rev. 2005, 26:331-45. 10.1210\/er.2004-0015","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s1566","article-title":"Long-term safety of aromatase inhibitors in the treatment of breast cancer","volume":"4","author":"Nabholtz JM","year":"2008","unstructured":"Nabholtz JM. Long-term safety of aromatase inhibitors in the treatment of breast cancer. Ther Clin Risk Manag. 2008, 4:189-204. 10.2147\/tcrm.s1566","journal-title":"Ther Clin Risk Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/01658107.2014.924968","article-title":"Bilateral optic disc swelling following anastrozole therapy","volume":"38","author":"Coppes OJ","year":"2014","unstructured":"Coppes OJ, Lukas RV, Fleming GF, Nichols J, Tenney M, Bernard J. Bilateral optic disc swelling following anastrozole therapy. Neuroophthalmology. 2014, 38:268-71. 10.3109\/01658107.2014.924968","journal-title":"Neuroophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2018.1700","article-title":"Association of uveitis and macular edema with anastrozole therapy","volume":"136","author":"Sathiamoorthi S","year":"2018","unstructured":"Sathiamoorthi S, Ruddy KJ, Bakri SJ. Association of uveitis and macular edema with anastrozole therapy. JAMA Ophthalmol. 2018, 136:837-9. 10.1001\/jamaophthalmol.2018.1700","journal-title":"JAMA Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0938.2012.00771.x","article-title":"Macular oedema due to letrozole: a first case report","volume":"95","author":"Moschos MM","year":"2012","unstructured":"Moschos MM, Chatziralli IP, Zagouri F, Zografos GC. Macular oedema due to letrozole: a first case report. Clin Exp Optom. 2012, 95:646-50. 10.1111\/j.1444-0938.2012.00771.x","journal-title":"Clin Exp Optom"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2014.1003267","article-title":"Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors","volume":"35","author":"Moschos MM","year":"2016","unstructured":"Moschos MM, Chatziralli IP, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos G. Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors. Cutan Ocul Toxicol. 2016, 35:13-20. 10.3109\/15569527.2014.1003267","journal-title":"Cutan Ocul Toxicol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.0064","article-title":"Association of crystalline retinopathy with anastrozole","volume":"137","author":"Wieder MS","year":"2019","unstructured":"Wieder MS, Harooni M, Rusu I. Association of crystalline retinopathy with anastrozole. JAMA Ophthalmol. 2019, 137:581-2. 10.1001\/jamaophthalmol.2019.0064","journal-title":"JAMA Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000218369","article-title":"Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole","volume":"32","author":"Karag\u00f6z B","year":"2009","unstructured":"Karag\u00f6z B, Ayata A, Bilgi O, et al.. Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole. Onkologie. 2009, 32:421-3. 10.1159\/000218369","journal-title":"Onkologie"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e31816bea3b","article-title":"Retinal hemorrhages in anastrozole users","volume":"85","author":"Eisner A","year":"2008","unstructured":"Eisner A, Falardeau J, Toomey MD, Vetto JT. Retinal hemorrhages in anastrozole users. Optom Vis Sci. 2008, 85:301-8. 10.1097\/OPX.0b013e31816bea3b","journal-title":"Optom Vis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0156-5","article-title":"Vitreo-retinal traction and anastrozole use","volume":"117","author":"Eisner A","year":"2009","unstructured":"Eisner A, Thielman EJ, Falardeau J, Vetto JT. Vitreo-retinal traction and anastrozole use. Breast Cancer Res Treat. 2009, 117:9-16. 10.1007\/s10549-008-0156-5","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3816\/CBC.2009.n.030","article-title":"Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitors","volume":"9","author":"Epstein RJ","year":"2009","unstructured":"Epstein RJ. Visual impairment in myopic patients with breast cancer receiving adjuvant therapy with aromatase inhibitors. Clin Breast Cancer. 2009, 9:184-6. 10.3816\/CBC.2009.n.030","journal-title":"Clin Breast Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/15569521003775013","article-title":"Exemestane-induced corneal epithelial changes","volume":"29","author":"Papathanassiou M","year":"2010","unstructured":"Papathanassiou M, Nikita E, Theodossiadis P, Theodossiadis GP, Vergados I. Exemestane-induced corneal epithelial changes. Cutan Ocul Toxicol. 2010, 29:209-11. 10.3109\/15569521003775013","journal-title":"Cutan Ocul Toxicol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.12633","article-title":"Ocular surface disease in breast cancer patients using aromatase inhibitors","volume":"22","author":"Chatziralli I","year":"2016","unstructured":"Chatziralli I, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos GC, Moschos M. Ocular surface disease in breast cancer patients using aromatase inhibitors. Breast J. 2016, 22:561-3. 10.1111\/tbj.12633","journal-title":"Breast J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01612-z","article-title":"The effects of systemic aromatase inhibitors on meibomian glands and corneal structure [In Press]","author":"A\u011f\u0131n A","year":"2021","unstructured":"A\u011f\u0131n A, Kocabeyoglu S, Yucel Gencoglu A, Aksoy S, Karakaya J, Irkec M. The effects of systemic aromatase inhibitors on meibomian glands and corneal structure [In Press]. Eye (Lond). 2021, 10.1038\/s41433-021-01612-z","journal-title":"Eye (Lond)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-020-01384-7","article-title":"The effects of adjuvant hormonotherapy on tear functions in patients with breast cancer","volume":"40","author":"Bicer T","year":"2020","unstructured":"Bicer T, Imamoglu GI, Dogan AS, Avarisli NA, Kabatas N, Bicer BK, Gurdal C. The effects of adjuvant hormonotherapy on tear functions in patients with breast cancer. Int Ophthalmol. 2020, 40:2077-83. 10.1007\/s10792-020-01384-7","journal-title":"Int Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2012.02865.x","article-title":"Dry eye syndrome in aromatase inhibitor users","volume":"41","author":"Turaka K","year":"2013","unstructured":"Turaka K, Nottage JM, Hammersmith KM, Nagra PK, Rapuano CJ. Dry eye syndrome in aromatase inhibitor users. Clin Exp Ophthalmol. 2013, 41:239-43. 10.1111\/j.1442-9071.2012.02865.x","journal-title":"Clin Exp Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65620-review-of-the-literature-on-ocular-complications-associated-with-aromatase-inhibitor-use","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:31Z","timestamp":1707507271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65620-review-of-the-literature-on-ocular-complications-associated-with-aromatase-inhibitor-use"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.17565","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}